A 24-Year Mortality Analysis of Spinal Muscular Atrophy and a Blueprint for Future Pediatric Care

from TheBrief.Health · host TheBrief.Health

A 24-year U.S. analysis shows gene-targeted therapies dramatically reduced childhood spinal muscular atrophy mortality, transforming a once-fatal disease into a manageable long-term condition.

Episode metadata supplied by the publisher feed · Published Jun 11, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

A 24-Year Mortality Analysis of Spinal Muscular Atrophy and a Blueprint for Future Pediatric Care

0:00 1:41

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of TheBrief.Health?

This episode is 1 minute long.

When was this TheBrief.Health episode published?

This episode was published on June 11, 2026.

Can I download this TheBrief.Health episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!